219 related articles for article (PubMed ID: 14616262)
1. Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix.
Chil A; Sikorski M; Bobek M; Jakiel G; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1146-52. PubMed ID: 14616262
[TBL] [Abstract][Full Text] [Related]
2. Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.
Cromme FV; Meijer CJ; Snijders PJ; Uyterlinde A; Kenemans P; Helmerhorst T; Stern PL; van den Brule AJ; Walboomers JM
Br J Cancer; 1993 Jun; 67(6):1372-80. PubMed ID: 8390286
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of selected MHC class I and II molecule expression in the course of HPV positive CIN treatment with the use of human recombinant IFN-gamma.
Sikorski M; Bobek M; Zrubek H; Marcinkiewicz J
Acta Obstet Gynecol Scand; 2004 Mar; 83(3):299-307. PubMed ID: 14995928
[TBL] [Abstract][Full Text] [Related]
4. HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix.
Torres LM; Cabrera T; Concha A; Oliva MR; Ruiz-Cabello F; Garrido F
Tissue Antigens; 1993 Feb; 41(2):65-71. PubMed ID: 8386400
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma.
Zhou JH; Ye F; Chen HZ; Zhou CY; Lu WG; Xie X
Life Sci; 2006 Apr; 78(22):2643-9. PubMed ID: 16434060
[TBL] [Abstract][Full Text] [Related]
6. The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma.
Hilders CG; Houbiers JG; Krul EJ; Fleuren GJ
Am J Clin Pathol; 1994 Jan; 101(1):5-12. PubMed ID: 7506480
[TBL] [Abstract][Full Text] [Related]
7. The expression of HLA-DR antigen in cervical neoplasia.
Raju GC; Teh M; Wee A
Cancer Detect Prev; 1994; 18(5):367-73. PubMed ID: 7812983
[TBL] [Abstract][Full Text] [Related]
8. Frequent HLA class I loss is an early event in cervical carcinogenesis.
Vermeulen CF; Jordanova ES; Zomerdijk-Nooijen YA; ter Haar NT; Peters AA; Fleuren GJ
Hum Immunol; 2005 Nov; 66(11):1167-73. PubMed ID: 16571417
[TBL] [Abstract][Full Text] [Related]
9. HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection.
Glew SS; Connor ME; Snijders PJ; Stanbridge CM; Buckley CH; Walboomers JM; Meijer CJ; Stern PL
Eur J Cancer; 1993; 29A(14):1963-70. PubMed ID: 8280490
[TBL] [Abstract][Full Text] [Related]
10. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
11. nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Lee CS; Gad J
Pathol Int; 1998 Oct; 48(10):806-11. PubMed ID: 9788265
[TBL] [Abstract][Full Text] [Related]
12. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.
Ryu KS; Lee YS; Kim BK; Park YG; Kim YW; Hur SY; Kim TE; Kim IK; Kim JW
Exp Mol Med; 2001 Sep; 33(3):136-44. PubMed ID: 11642549
[TBL] [Abstract][Full Text] [Related]
13. Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia.
Hughes RG; Norval M; Howie SE
J Clin Pathol; 1988 Mar; 41(3):253-9. PubMed ID: 2834416
[TBL] [Abstract][Full Text] [Related]
14. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium.
Mota F; Rayment N; Chong S; Singer A; Chain B
Clin Exp Immunol; 1999 Apr; 116(1):33-40. PubMed ID: 10209502
[TBL] [Abstract][Full Text] [Related]
15. Laminin receptor 1 expression in premalignant and malignant squamous lesions of the cervix.
Kurdoğlu M; Kurdoğlu Z; Küçükaydın Z; Erten R; Bulut G; Özen S
Biotech Histochem; 2024 Apr; 99(3):174-181. PubMed ID: 38736402
[TBL] [Abstract][Full Text] [Related]
16. Altered expression levels of HLA class Ⅱ and costimulatory molecules on circulating monocytes from patients with cervical intraepithelial neoplasia and squamous cervical cancer.
Feng T; Zhou JH; Liu J; Ye F; Lu W; Xie X
Mol Med Rep; 2012 Dec; 6(6):1301-4. PubMed ID: 22965188
[TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical study of p53 protein in cervical intraepithelial neoplasia and squamous cell carcinoma.
Raju GC; Teh M; Wee A
Pathology; 1996 Jan; 28(1):17-19. PubMed ID: 8714263
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of hedgehog signaling molecules in squamous cell carcinoma of uterine cervix and its precursor lesions.
Xuan YH; Jung HS; Choi YL; Shin YK; Kim HJ; Kim KH; Kim WJ; Lee YJ; Kim SH
Mod Pathol; 2006 Aug; 19(8):1139-47. PubMed ID: 16778829
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
Bonds L; Baker P; Gup C; Shroyer KR
Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
[TBL] [Abstract][Full Text] [Related]
20. Expression of beta 2-microglobulin by premalignant epithelium.
Petersen BL; Petersen CL; Braendstrup O; Mouritsen S; Engel AM; Svane IM; Werdelin O
APMIS; 1993 Jul; 101(7):529-36. PubMed ID: 8398092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
